Recruitment

Recruitment Status
Not yet recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • FATTY LIVER
  • Fatty Liver Disease
  • NAFLD
  • NASH
  • Non Alcoholic Fatty Liver
  • Non Alcoholic Fatty Liver Disease
  • Non Alcoholic Steatohepatitis
Type
Observational
Design
Observational Model: CohortTime Perspective: Prospective

Participation Requirements

Age
Between 18 years and 70 years
Gender
Both males and females

Description

Patients with either known or presumed diagnosis of non-alcoholic fatty liver disease who meets eligibility criteria will be included in the study. They will have imaging done to estimate hepatic steatosis by two modalities (MRI - PDFF and thermo-acoustic ultrasound). The estimation obtained by ther...

Patients with either known or presumed diagnosis of non-alcoholic fatty liver disease who meets eligibility criteria will be included in the study. They will have imaging done to estimate hepatic steatosis by two modalities (MRI - PDFF and thermo-acoustic ultrasound). The estimation obtained by thermo-acoustic ultrasound will be compared with MRI results for accuracy of estimation by the thermo-acoustic ultrasound device. The study will also evaluate the sensitivity of the thermo-acoustic ultrasound device if it can diagnose the presence of hepatic steatosis when hepatic fat content is 15% or less by volume.

Tracking Information

NCT #
NCT04302051
Collaborators
ENDRA Life Sciences, Inc.
Investigators
Principal Investigator: ACHUTHAN SOURIANARAYANANE, MD Medical College of Wisconsin